Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease

被引:5
作者
Zhang, Tianxiao [1 ]
Wang, Xiaodan [2 ]
Zhang, Yueying [2 ]
Yang, Ying [1 ]
Yang, Congying [1 ]
Wei, Huiyi [3 ]
Zhao, Qingbin [2 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, Xian 710061, Shaanxi, Peoples R China
[3] Yanan Univ, Sch Med, Yanan 716000, Shaanxi, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Weighted risk model; Diabetic kidney disease; Progression; Random forest; Dialysis; GLOMERULAR-FILTRATION-RATE; SERUM URIC-ACID; OUTCOMES; UPDATE; HYPERFILTRATION; ASSOCIATION; PREVALENCE; MANAGEMENT; HEALTH; IMPACT;
D O I
10.1186/s12967-023-04245-w
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundDiabetic kidney disease (DKD) is a severe complication of diabetes. Currently, no effective measures are available to reduce the risk of DKD progression. This study aimed to establish a weighted risk model to determine DKD progression and provide effective treatment strategies.MethodsThis was a hospital-based, cross-sectional study. A total of 1104 patients with DKD were included in this study. The random forest method was used to develop weighted risk models to assess DKD progression. Receiver operating characteristic curves were used to validate the models and calculate the optimal cutoff values for important risk factors.ResultsWe developed potent weighted risk models to evaluate DKD progression. The top six risk factors for DKD progression to chronic kidney disease were hemoglobin, hemoglobin A1c (HbA1c), serum uric acid (SUA), plasma fibrinogen, serum albumin, and neutrophil percentage. The top six risk factors for determining DKD progression to dialysis were hemoglobin, HbA1c, neutrophil percentage, serum albumin, duration of diabetes, and plasma fibrinogen level. Furthermore, the optimal cutoff values of hemoglobin and HbA1c for determining DKD progression were 112 g/L and 7.2%, respectively.ConclusionWe developed potent weighted risk models for DKD progression that can be employed to formulate precise therapeutic strategies. Monitoring and controlling combined risk factors and prioritizing interventions for key risk factors may help reduce the risk of DKD progression.
引用
收藏
页数:11
相关论文
共 40 条
  • [21] Effects of glycaemic management on diabetic kidney disease
    MacIsaac, Richard J.
    Jerums, George
    Ekinci, Elif I.
    [J]. WORLD JOURNAL OF DIABETES, 2017, 8 (05) : 172 - 186
  • [22] Uric acid and risk of diabetic kidney disease
    Mauer, Michael
    Doria, Alessandro
    [J]. JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 995 - 999
  • [23] Impact of inflammatory markers on the relationship between sleep quality and diabetic kidney disease
    Meng, Lingling
    Ding, Yi
    Li, Jiarui
    Li, Xiaodong
    Yan, Tiantian
    Yang, Min
    Song, Hongna
    Lv, Shiyu
    Wang, Na
    Li, Yuzhu
    Zhang, Min
    Ni, Changlin
    Tang, Yunzhao
    Li, Daiqing
    [J]. SLEEP AND BREATHING, 2022, 26 (01) : 157 - 165
  • [24] Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
    Menke, Andy
    Casagrande, Sarah
    Geiss, Linda
    Cowie, Catherine C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (10): : 1021 - 1029
  • [25] The Many Faces of Infection in CKD: Evolving Paradigms, Insights, and Novel Therapies
    Narayanan, Mohanram
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 5 - 7
  • [26] The impact of hyperfiltration on the diabetic kidney
    Premaratne, E.
    Verma, S.
    Ekinci, E. I.
    Theverkalam, G.
    Jerums, G.
    MacIsaac, R. J.
    [J]. DIABETES & METABOLISM, 2015, 41 (01) : 5 - 17
  • [27] Saran R, 2015, AM J KIDNEY DIS, V66, P545, DOI 10.1053/j.ajkd.2015.05.001
  • [28] Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
    Saulnier, Pierre-Jean
    Wheelock, Kevin M.
    Howell, Scott
    Weil, E. Jennifer
    Tanamas, Stephanie K.
    Knowler, William C.
    Lemley, Kevin V.
    Mauer, Michael
    Yee, Berne
    Nelson, Robert G.
    Beisswenger, Paul J.
    [J]. DIABETES, 2016, 65 (12) : 3744 - 3753
  • [29] An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
    Selby, Nicholas M.
    Taal, Maarten W.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 : 3 - 15
  • [30] Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
    Sharma, Gaurav
    Dubey, Abhishek
    Nolkha, Nilesh
    Singh, Jasvinder A.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13